GLP-1 Pills Are Already Upending the Obesity-Drug Market

Published on February 9, 2026

For the last year, any discussion of the obesity-drug market has come with an asterisk: Everything will change once pill versions of the popular GLP-1 drugs arrive. Those potentially cheaper alternative to injectables could mean a larger slice of the millions of Americans with obesity will try out the medicine.

Continue reading on website
Other news

Expect the Unexpected

February 9, 2026
Barely a month into 2026, markets have already weathered multiple bouts of rolling, event‑driven volatility. Geopolitical surprises and policy pivots have triggered sharp price moves from the U.S. to Japan to Europe, from sovereign bonds to currencies to mortgages.

Blockchain’s Emerging Universal Liquidity Layer

February 9, 2026
Buildout of blockchain-based infrastructure is entering a new phase. The focus in 2025 was on stablecoins and their emergence as the cross-over use case that captured interest from both crypto-native and traditional financial participants.